EPHX2 and neuropathy: In addition, SMTP-44D could have ameliorated neuropathy by exerting effects in addition to the inhibition of sEH C-terminal domain epoxide hydrolase (C-EH) since SMTP-44D inhibits N-terminal domain phosphatase activity along with the C-EH [19,40].